Haemostatic derangement in advanced peripheral occlusive arterial disease

International Angiology

Volumn 18, Issue 4, 1999, Pages 256-262

  Koksch, M ^a   Zeiger, F ^b   Wittig, K ^b   Pfeiffer, D ^b   Ruehlmann, C ^b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b NONE

Author keywords

Arterial occlusive disease; Blood coagulation; Blood platelets; Fibrinolysis; Peripheral vascular disease

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTITHROMBIN III; FIBRINOGEN; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ANGIOGRAPHY; ARTICLE; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; HUMAN TISSUE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOGENESIS;

ARTERIAL OCCLUSIVE DISEASES; BLOOD PLATELET DISORDERS; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYSIS; FLOW CYTOMETRY; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PERIPHERAL VASCULAR DISEASES;

EID: 0033511578     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.
2. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: Importance of identifying the population at risk. Vasc Med 1997;2:221-6.
3. Fowkes FGR, Housley E, Cawood EHH, Macintire CCA, Ruckey CV, Prescott RJ. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.
4. Fox R. Trends in cardiovascular mortality in Europe. Circulation 1997;96:3817.
5. Al-Zahrani H, Lowe GDO, Douglas JT, Cuschieri R, Pollock JG, Smith WCS. Increased fibrin turnover in peripheral arterial disease: Comparison with a population study. Clin Hemorheol 1992:12:867-72.
6. De Buyzere M, Philippe J, Duprez D, Baele G, Clement DL. Coagulation system activation and increase in D-dimer levels in peripheral arterial occlusive disease. Am J Hematol 1993;43:91-4.
7. Reininger CB, Graf J, Reininger AJ, Spannagl M, Steckmeier B, Schweiberer L. Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease. Thromb Res 1996;82: 523-32.
8. Lassila R, Peltonen S, Lepantalo M, Saarinen O, Kauhanen P, Manninen V. Severity of peripheral atherosclerosis is associated with librinogen and degradation of cross-linked fibrin. Arterioscler Thromb 1993;13:1738-42.
9. Fowkes FGR, Lowe GDO, Housley E, Rattray A, Rumley A, Elton RA et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993;342:84-6.
10. Cortellaro M, Cofrancesco E, Boschetti E, Mussoni L, Donati MB, Cardillo M et al. and the PLAT group. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients: A case-control study. Arterioscler Thromb 1993;13:1412-7.
11. Cortellaro M, Cofrancesco E, Boschetti E, Mussoni L, Donati MB, Catalano M et al. and the PLAT group. Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. Thromb Haemost 1994;72:292-6.
12. Zahavi J, Zahavi M. Enhanced platelet release, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. Thromb Haemost 1985;53:105-9.
13. Minar E, Ehringer H, Jung M, Koppensteiner R, Stuempflen A. Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, β-thromboglobulin and PF4 in patients with peripheral arterial occlusive disease. Thromb Res 1988;52: 219-26.
14. Gresele P, Catalano M, Giammarresi C, Volpato R, Termini R, Ciabattoni G et al. Platelet activation markers in patients with peripheral arterial disease: A prospective comparison of different platelet function tests. Thromb Haemost 1997;78:1434-7.
15. Galt SW, McDaniel MD, Ault KA, Mitchell J, Cronenwett JL. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease. J Vasc Surg 1991;14:747-55.
16. Reininger CB, Reininger AJ, Hoermann A, Steckmeier B, Schweiberer L. Quantitative analysis of platelet function using stagnation point flow aggregometry. Int Angiol 1992;11:247-55.
17. Reininger CB, Reininger AJ, Graf J, Eibl-Eibesfeldt BI, Steckmeier B. Real-time analysis of platelet adhesion under stagnation point flow conditions: The effect of red blood cells and glycoprotein IIb/IIIa receptor blockade. J Vasc Invest 1996;2:1-11.
18. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645-58.
19. Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg 1986;4:80-94.
20. Bollinger A, Breddin K, Hess H, Heystraten FMJ, Kollath J, Konttila A et al. Semi-quantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis 1981;38:339-46.
21. Becker RC, Tracy RP, Bovill EG, Mann KG, Ault K. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group. Coron Artery Dis 1994;5:339-45.
22. Nurden AT, Macchi L, Bihour C, Durrieu C, Besse P, Burden P. Markers of platelet activation in coronary heart disease patients. Eur J Clin Invest 1994;24:42-5.
23. Itoh T, Nakai K, Ono M, Hiramori K. Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker P-selectin? Coron Artery Dis 1995;6:645-50.
24. Gawaz M, Neumann FJ, Ott I, Schiessler A, Schomig A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 1996;93: 229-37.
25. Scharf RE, Tomer A, Marzec UM, Teirstein PS, Ruggeri ZM, Harker LA. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb 1992;12: 1475-87.
26. Markovitz JH, Roubin GS, Parks JM, Bittner V. Platelet activation and re-stenosis after coronary stenting: Flow cytometric detection of wound-induced platelet activation. Coron Artery Dis 1996;7:657-65.
27. Wahba A, Black G, Koksch M, Rothe G, Preuner J, Schmitz G et al. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass. Thromb Haemost 1996;75:844-8.
28. Wahba A, Black G, Koksch M, Rothe G, Preuner J, Schmitz G et al. Cardiopulmonary bypass leads to a preferential loss of activated platelets. A flow cytometric assay of platelet surface antigens. Eur J Cardiothorac Surg 1996;10:768-73.
29. Nomura S, Komiyama Y, Murakami T, Funatsu A, Kokawa T, Sugo T et al. Flow cytometric analysis of surface membrane proteins on activated platelets and platelet-derived microparticles from healthy and thrombasthenic individuals. Int J Hematol 1993;58: 203-12.
30. Chang CP, Zhao J, Wiedmer T, Sims PJ. Contribution of platelet microparticle formation of the transmembrane migration of phosphatidylserine. J Biol Chem 1993;268:7171-8.
31. +2 ATPase inhibitors. Biochemistry 1995;34:11625-34.
32. Hoffman M, Monroe DM, Roberts HR. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: A flow cytometric study. Thromb Haemost 1992;68:74-8.
33. Badimon L, Badimon JJ, Chesebro JH, Fuster V. von Willebrand factor and cardiovascular disease. Thromb Haemost 1993;70:111-8.
34. Lip GYH, Blann AD. von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J 1995,74:580-3.
35. van der Bom JG, Bots ML, van Vliet HH, Pols HA, Hofman A, Grobbee DE. Antithrombin and atherosclerosis in the Rotterdam Study. Arterioscler Thromb Vasc Biol 1996;16:864-7.